Florio v. Skorepa (1995)

See Daubert v. Merrell Dow Pharmaceuticals, Inc., 43 F.3d 1311, 1315-16 (9th Cir.), cert. denied, 516 U.S. 869 (1995) ("[S]omething doesn't become `scientific knowledge' just because it's uttered by a scientist; nor can an expert's self-serving assertion that his Conclusions were `derived by the scientific method' be deemed conclusive....").

See Daubert v. Merrell Dow Pharmaceuticals, Inc., 43 F.3d 1311, 1315-16 (9th Cir.), cert. denied, 516 U.S. 869 , 116 S.Ct. 189 , 133 L.Ed.2d 126 (1995) (“[S]omething doesn’t become ‘scientific knowledge’ just because it’s uttered by a scientist; nor can an expert’s self-serving assertion that his conclusions were ‘derived by the scientific method’ be deemed conclusive....”).

See id. (“officers may presume that a person is at home at certain times of the day”).

Daubert v. Merrell Dow Pharms., Inc., 43 F.3d 1311, 1315 (9th Cir.), cert. denied 516 U.S. 869 , 116 S.Ct. 189 , 133 L.Ed.2d 126 (1995) (“Daubert II”).

Inc., 43 F.3d 1311 , 1315 (9th Cir.), cert. denied 516 U.S. 869 , 116 S.Ct. 189 , 133 L.Ed.2d 126 (1995) (“Daubert II”) (quoting Daubert v. Merrell Dow Pharms.

Inc., 43 F.3d 1311 , 1315 (9th Cir.), cert. denied 516 U.S. 869 , 116 S.Ct. 189 , 133 L.Ed.2d 126 (1995) (" Daubert II ") (quoting Daubert v. Merrell Dow Pharms.

Boeing also argues that Siskin’s analyses do not speak “clearly and directly to an issue in dispute in the ease.” Id. at 6, citing Daubert v. Merrell Dow Pharms., Inc., 43 F.3d 1311 , 1321 n. 17 (9th Cir.), cert, denied, 516 U.S. 869 , 116 S.Ct. 189 , 133 L.Ed.2d 126 (1995) (“Daubert II”).

Daubert v. Merrell Dow Pharmaceuticals, Inc., 43 F.3d 1311, 1320 (9th Cir.), cert denied, 516 U.S. 869 , 116 S.Ct. 189 , 133 L.Ed.2d 126 (1995)(“Daubert II”).

See United States v. Magluta, 44 F.3d 1530, 1535 (11th Cir.), cert. denied, 516 U.S. 869 (1995) (“officers may presume that a person is at home at certain times of the day”); United States v. Terry, 702 F.2d 299, 319 (2d Cir.), cert. denied sub nom.

Fed.R.Evid. 702; see, e.g., Daubert v. Merrell Dow Pharm., 43 F.3d 1311, 1316 (9th Cir.), cert. denied, 516 U.S. 869 , 116 S.Ct. 189 , 133 L.Ed.2d 126 (1995) CDaubert II).

Accord United States v. Magluta, 44 F.3d 1530, 1535 (11th Cir.) (reversing grant of motion to suppress, stating that “in order for law enforcement officials to enter a residence to execute an arrest warrant for a resident of the premises, the facts and circumstances within the knowledge of the law enforcement agents, when viewed in the totality, must warrant a reasonable belief that the location to be searched is the suspect’s dwelling, and that the suspect is within the res…

See, e.g., Daubert v. Merrell Dow Pharmaceuticals, Inc., 43 F.3d 1311, 1317 (9th Cir.), cert. denied, 516 U.S. 869 (1995).

See Daubert v. Merrell Dow Pharmaceuticals, Inc., 43 F.3d 1311, 1315 (9th Cir.), cert. denied, 516 U.S. 869 , 116 S.Ct. 189 , 133 L.Ed.2d 126 (1995) 4 We have recently held that the Supreme Court's decision in Daubert did overrule Brown's per se prohibition against unstipulated polygraph evidence.

Circuit's observation, "We think it more likely ... that the Supreme Court in Pay-ton used a phrase other than 'probable cause' because it meant something other than 'probable cause."" Thomas, 429 F.3d at 286 ; see also United States v. Magluta, 44 F.3d 1530, 1534 (11th Cir.1995) ("The strongest support for a lesser burden than probable cause remains the text of Payton, and what we must assume was a conscious effort on the part of the Supreme Court in choosing the verbal for…

Evid. 702(a)); see also Daubert v. Merrell Dow Pharmaceuticals 10 (“Daubert II”), 43 F.3d 1311 , 1315 (9th Cir. 1995) (relevant evidence is that which “logically 11 advances a material aspect of the proposing party’s case”), cert. denied, 516 U.S. 869 (1995). 12 Expert testimony is reliable if it is “based on sufficient facts or data,” “is the product of 13 reliable principles and methods,” and “reflects a reliable application of the principles and 14 methods to the facts of…

Evid. 702(a)); see also Daubert v. Merrell Dow Pharmaceuticals 8 (“Daubert II”), 43 F.3d 1311 , 1315 (9th Cir. 1995) (relevant evidence is that which “logically 9 advances a material aspect of the proposing party’s case”), cert. denied, 516 U.S. 869 (1995). 10 Expert testimony is reliable if it is “based on sufficient facts or data,” “is the product of 11 reliable principles and methods,” and “reflects a reliable application of the principles and 12 methods to the facts of t…

Evid. 702(a)); see also Daubert v. Merrell Dow Pharmaceuticals 4 (“Daubert II”), 43 F.3d 1311 , 1315 (9th Cir. 1995) (relevant evidence is that which “logically 5 advances a material aspect of the proposing party’s case”), cert. denied, 516 U.S. 869 (1995). 6 Expert testimony is reliable if it is “based on sufficient facts or data,” “is the product of 7 reliable principles and methods,” and “reflects a reliable application of the principles and 8 methods to the facts of the …

Evid. 702(a)); see also Daubert v. Merrell Dow Pharmaceuticals 19 (“Daubert II”), 43 F.3d 1311 , 1315 (9th Cir. 1995) (relevant evidence is that which “logically 20 advances a material aspect of the proposing party’s case”), cert. denied, 516 U.S. 869 (1995). 21 Expert testimony is reliable if it is “based on sufficient facts or data,” “is the product of 22 reliable principles and methods,” and “reflects a reliable application of the principles and 23 methods to the facts of…

However, as this implication is drawn not from her express argument but instead her declaration she will not address Martin’s qualified immunity defense because “[t]here was a clear constitutional violation here,” the Court is left with an underdeveloped argument as to why qualified immunity should not apply. 21 Circuit, in interpreting Payton, settled on a two-part analysis for determining whether police entry into a private residence was lawful: “(1) whether there is reaso…

See Gates v. Victor Fine Foods, 54 F.3d 1457, 1466 (9th Cir.1995), cert, denied, 516 U.S. 869 , 116 S.Ct. 187 , 133 L.Ed.2d 124 (1995) (refusing to expand waiver to encompass unrelated action).

See Daubert v. Merrell Dow Pharmaceuticals, Inc., 43 F3d 1311, 1317 (9th Cir), cert den, 516 US 869 (1995).

See Daubert v. Merrell Dow Pharm., Inc., 43 F.3d 1311 , 1319 & n. 11 (9th Cir.1995), ce rt. denied, 516 U.S. 869 , 116 S.Ct. 189 , 133 L.Ed.2d 126 (1995) (noting that the key under Daubert is whether "a recognized minority” accepts a theory or methodology as valid). 12 .

(See People v. Zapien (1993) 4 Cal.4th 929, 989 [ 17 Cal.Rptr.2d 122 , 846 P.2d 704 ].) To borrow from the District of Columbia Circuit’s observation, “[w]e think it more likely . . . that the Supreme Court in Payton used a phrase other than ‘probable cause’ because it meant something other than ‘probable cause.’ ” (U.S. v. Thomas, supra, 429 F.3d at p. 286 ; see also U.S. v. Magluta, supra, 44 F.3d at p. 1534 [“[t]he strongest support for a lesser burden than probable cause…

See Daubert v. Merrell Dow Pharmaceuticals, Inc., 43 F.3d 1311, 1320 (9th Cir.), cert denied, 516 U.S. 869 , 116 S.Ct. 189 , 133 L.Ed.2d 126 (1995); see also In re W.R.

See Daubert v. Merrell Dow Pharm., Inc. , 516 U.S. 869 , 116 S. Ct. 189 (1995); Jordan v. State , 928 S.W.2d 550, 554 (Tex. Crim.

May field and Allen in 2008. 16 Finders of fact are cautioned to consider the possible bias of an expert witness “including any bias you may infer from evidence that the expert witness has been or will be paid for reviewing the case and testifying, or from evidence that he testifies regularly as an expert witness and his income from such testimony represents a significant portion of his income.” Fifth Circuit Pattern Jury Instructions—Civil Cases, Pattern Instruction 2.19, p…

See, e.g., Daubert v. Merrell Dow Pharmaceuticals, Inc., 43 F.3d 1311 , 1317 n. 4 (9th Cir.) (Kozinski, J.), cert. denied, 516 U.S. 869 , 116 S.Ct. 189 , 133 L.Ed.2d 126 (1995).

See Daubert v. Merrell Dow Pharmaceuticals, Inc., 43 F.3d 1311 , 1319 n. 10 (9th Cir. 1995), cert. denied, 516 U.S. 869 , 116 S.Ct. 189 , 133 L.Ed.2d 126 (1995); see also G.

See id. (citing Daubert v. Merrell Dow Pharms., Inc., 43 F.3d 1311 , 1316 (9th Cir.1995) (on remand), ce rt. denied, 516 U.S. 869 , 116 S.Ct. 189 , 133 L.Ed.2d 126 (1995)).

See id. (citing Daubert v. Merrell Dow Pharms., Inc., 43 F.3d 17 1311, 1316 (9th Cir. 1995) (on remand), cert. denied, 516 U.S. 869 , 116 S. Ct. 189 (1995).

See id. (citing Daubert v. Merrell Dow Pharms., Inc. , 43 F.3d 1311 , 1316 (9th Cir. 1995) (on remand), cert. denied , 516 U.S. 869 , 116 S. Ct. 189 (1995).

Fed.R.Evid. 702; see, e.g., Daubert v. Merrell Dow Pharm., 43 F.3d 1311, 1316 (9th Cir.), cert. denied, 516 U.S. 869 , 116 S.Ct. 189 , 133 L.Ed.2d 126 (1995) (Daubert II). 9.In challenging plaintiffs proposed expert testimony, defendant is not required to come forward with “scientific evidence” negating plaintiffs claims.

See Daubert v. Merrell Dow Pharmaceuticals, Inc., 43 F.3d 1311, 1317 (9th Cir.), cert. denied, 516 U.S. 869, 116 S.Ct. 189 , 133 L.Ed.2d 126 (1995) (“One very significant fact to be considered is whether the experts are proposing to testify about matters growing naturally and directly out of research they have conducted independent of the litigation, or whether they have developed their opinions expressly for purposes of testifying.”).

In re AMC Realty Corp., 270 B.R. 132, 140-41 (Bankr.S.D.N.Y.2001); see also In re Trident Assoc., Ltd., 52 F.3d 127 , 131 (6th Cir.1995), cert. denied, 516 U.S. 869 , 116 S.Ct. 188 , 133 L.Ed.2d 125 (1995).

“While probable cause itself is a relatively low threshold of proof, it is a higher standard than ‘reasonable belief, which is, as everyone agrees, the appropriate standard.” Valdez v. McPheters, 172 F.3d at 1227 n. 5 (citation omitted). “[T]he officers’ assessment need not in fact be correct; rather, they need only ‘reasonably believe’ that the suspect resides at the dwelling to be searched and is currently present at the dwelling.” United States v. Risse, 83 F.3d 212, 216 …

In Payton , the Supreme Court also decided that “an arrest warrant founded on probable cause implicitly carries with it the limited authority to enter a dwelling in which the suspect lives when there is reason to believe the suspect is within.” 445 U.S. at 603-04 , 100 S.Ct. 1371 . “ ‘Because an arrest warrant authorizes the police to deprive a person of his liberty, it necessarily also authorizes a limited invasion of that person’s privacy interest when it is necessary to a…

See Daubert v. Merrell Dow Pharmaceuticals, Inc., 43 F.3d 1311 (9th Cir.1995), cert. denied, 516 U.S. 869 , 116 S.Ct. 189 , 133 L.Ed.2d 126 (1995) (proceedings after remand) (where opposing party raises a material dispute regarding admissibility of expert scientific evidence, court must hold a hearing).

United States v. Lauter, 57 F.3d 212, 215 (2d Cir.1995); see also United States v. Magluta, 44 F.3d 1530, 1535 (11th Cir.), cert. denied, 516 U.S. 869 , 116 S.Ct. 189 , 133 L.Ed.2d 126 (1995)(emphasis added).

See Daubert v. Merrell Dow Pharm., Inc., 43 F.3d 1311 , 1316 (9th Cir.), cert. den., 516 U.S. 869 , 116 S.Ct. 189 , 133 L.Ed.2d 126 (1995) (party presenting expert must show that expert’s findings are based on sound scientific method).